The Alert app system that is being tested in the Embrace clinical trial (in the United States) is currently aiming to do real-time convulsive seizure detection where we have seen very high detection rates and low false alarm rates in past research with our technology (in the hospital setting).
The Alert app notifies your loved ones when you need help. You can download the app for free. Alert app comes with free and paid subscription plans. We are working on the applicable fee for the paid subscriptions, but we are aiming at maintaining it as low as possible. The pre-orders placed before September 1st, 2016 will include 6 months of Premium Service, while for the orders placed after September 1st, 2016 we'll include 3 months of Premium Service.